Last week, Germany’s Federal Ministry of Health has adjusted the rules governing Digital Health Applications (DiGA) once more. Key changes include new reporting obligations that require manufacturers to measure and document the success of their digital health apps. This reform adds notable operational pressure, while the reported outcomes will directly affect the prices of the
About
Latest Post
More Posts
German Government launches new Pharma & MedTech Dialogue – Broad agenda, big hopes but unclear prospects
European Commission Announces (Long Awaited) Proposal to Simplify EU Medical Device Regulations